Werner Brouwer

Werner Brouwer

Auto-generated profile, based on publicly available information

Werner Brouwer

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Value in Health
Verified
Journal Article
Closed access
CBClazien Bouwmans
Clazien Bouwmans
MKMarieke Krol
Marieke Krol
HSHans Severens
Hans Severens
MKMarc Koopmanschap
Marc Koopmanschap
WBWerner Brouwer
Werner Brouwer
LRLeona Hakkaart-Van Roijen
Leona Hakkaart-Van Roijen

1 August 2006 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
WBW. B. F. Brouwer
W. B. F. Brouwer
NEN.J.A. Van Exel
N.J.A. Van Exel
BGB. van Gorp
B. van Gorp
WRW. K. Redekop
W. K. Redekop

1 February 2004 in The European Journal of Health Economics
Verified
Journal Article
Closed access
PDF file
BBBernard van Den Berg
Bernard van Den Berg
WBWerner B. F. Brouwer
Werner B. F. Brouwer
MKMarc A. Koopmanschap
Marc A. Koopmanschap

19 May 2018 in PharmacoEconomics
Verified
Journal Article
Open access
PDF file
AAArthur E. Attema
Arthur E. Attema
WBWerner B. F. Brouwer
Werner B. F. Brouwer
KCKarl Claxton
Karl Claxton
Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for and height of the discount rate, whether costs and effects should be discounted at the same rate, and whether discount rates should decline or stay constant over time. Moreover, the choice for discount rules depends on the decision context one adopts as the most relevant. In this article, we review these issues and debates, and describe and discuss the current discounting recommendations of the countries publishing their national guidelines. We finish the article by proposing a research agenda.

1 March 2008 in Journal of Health Economics
Verified
Journal Article
Closed access
WBWerner B.F. Brouwer
Werner B.F. Brouwer
ACAnthony J. Culyer
Anthony J. Culyer
NEN.J.A. Van Exel
N.J.A. Van Exel
FRFrans F.H. Rutten
Frans F.H. Rutten

7 February 2014 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
MKMarieke Krol
Marieke Krol
WBWerner Brouwer
Werner Brouwer